Medical Condition News

RSS

Seattle Genetics brentuximab vedotin, dacetuzumab clinical data to be presented at ICML 2011

Seattle Genetics, Inc. today announced that data from its brentuximab vedotin and dacetuzumab programs will be presented at the 11th International Conference on Malignant Lymphoma being held June 15-18, 2011 in Lugano, Switzerland.

16 Jun 2011

Study establishes potential genetic link to human REM sleep behaviour disorder

Researchers at the University of Toronto are the first to indentify a potential cause for a severe sleep disorder that has been closely linked to Parkinson's disease and other neurodegenerative diseases.

16 Jun 2011

Positive results from SKP-1041 Phase 2 study in insomnia patients with MOTN awakenings

Results of a Phase 2 study sponsored by Somnus Therapeutics, Inc., add further evidence supporting the efficacy and safety of a novel bedtime therapeutic that addresses a major underserved need of insomnia patients: maintaining sleep.

16 Jun 2011

Phosphate regulating hormone associated with increased risk of kidney failure and death among CKD patients

A high level of a hormone that regulates phosphate is associated with an increased risk of kidney failure and death among chronic kidney disease (CKD) patients, according to a recent study led by researchers at the University of Miami and funded by the National Institute of Diabetes and Digestive Diseases and Kidney Diseases (NIDDK) at the National Institutes of Health.

16 Jun 2011

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

DiagnoCure, Inc., a life sciences company commercializing high‐value cancer diagnostic tests and delivering laboratory services, today reported the issuance of a new U.S. patent, which represents a significant addition to DiagnoCure's PCA3 prostate cancer biomarker portfolio.

16 Jun 2011

Platelet Derived Growth Factor Receptor-beta plays key role in onset of obesity

A new study from Mount Sinai School of Medicine has found that a cellular signaling pathway governs the differentiation of cells into fat tissue or smooth muscle, which lines the vascular system. Engaging this signaling pathway and its capacity to govern cell differentiation has important implications in preventing obesity and cardiovascular disease.

16 Jun 2011

Magical thinking may help consumers cope with stressful situations

Magical thinking, usually dismissed as na-ve and irrational, can actually help consumers cope with stressful situations like trying to lose weight, according to a new study in the Journal of Consumer Research.

16 Jun 2011

Non-invasive intervention can greatly improve patients' inhibitory control

Inhibitory control can be boosted with a mild form of brain stimulation, according to a study published in the June 2011 issue of Neuroimage, Elsevier's Journal of Brain Function.

16 Jun 2011

UC Irvine researchers discover top six risk factors for weight loss surgery

University of California at Irvine (UC Irvine) researchers reviewed data from more than 100,000 bariatric surgery patients and discovered the top six risk factors that could help doctors and patients predict, evaluate, reduce or avoid in-hospital mortality after weight loss surgery.

16 Jun 2011

Fred Hutchinson Cancer Research Center to relaunch online smoking-cessation study

Fred Hutchinson Cancer Research Center announced today that it is relaunching an online study to help people quit smoking. The study, called WebQuit, is enrolling adult smokers nationwide. Participation is free to eligible individuals.

16 Jun 2011

Train the brain to manage chronic pain

How do you function when chronic pain is a part of your daily life? The UC San Diego Center for Mindfulness (UCSD CFM) at UC San Diego Health System offers a novel program to help people who are dealing with chronic pain "train their brains" to lessen their experience of discomfort and, in some cases, eliminate it.

16 Jun 2011

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

Cambridge Biomedical, Neogenix partner to develop ELISA assays for pancreatic and colorectal cancer

Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.

16 Jun 2011

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

UCSF's Robert Blelloch, MD, PhD, has received the 2011 Outstanding Young Investigator Award from the International Society for Stem Cell Research, for his pioneering research on the role of molecular tools known as microRNAs in embryonic stem cells and cancer.

16 Jun 2011

ACC to expand partnership and strategic alliance with FIGMD

FIGMD, Inc. today announced the American College of Cardiology (ACC) will expand its partnership and strategic alliance with FIGMD by making an equity investment.

16 Jun 2011

Healthy diet, antioxidants, critical nutrients and activities may provide the foundation to youthful living

As the baby boomer generation continues to increase in age, so does its passion to remain youthful, both inside and out. Beating the clock is now a multi-faceted, science-driven industry. From its age-old quests to find the elixir of life, to modern exploration of how microcellular activity contributes to metabolic breakdown, scientific research continues to advance its goals to enhance bodily energy, vigour and performance, and fade or stall the visible signs of aging.

16 Jun 2011

Liraglutide medication can help treat type 1 diabetes

Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.

16 Jun 2011

Medical Condition News

Seattle Genetics brentuximab vedotin, dacetuzumab clinical data to be presented at ICML 2011

Study establishes potential genetic link to human REM sleep behaviour disorder

Positive results from SKP-1041 Phase 2 study in insomnia patients with MOTN awakenings

Phosphate regulating hormone associated with increased risk of kidney failure and death among CKD patients

DiagnoCure receives new U.S. patent for PCA3 prostate cancer biomarker portfolio

Platelet Derived Growth Factor Receptor-beta plays key role in onset of obesity

Magical thinking may help consumers cope with stressful situations

Non-invasive intervention can greatly improve patients' inhibitory control

UC Irvine researchers discover top six risk factors for weight loss surgery

Fred Hutchinson Cancer Research Center to relaunch online smoking-cessation study

Train the brain to manage chronic pain

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

Cambridge Biomedical, Neogenix partner to develop ELISA assays for pancreatic and colorectal cancer

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

ACC to expand partnership and strategic alliance with FIGMD

Healthy diet, antioxidants, critical nutrients and activities may provide the foundation to youthful living

Liraglutide medication can help treat type 1 diabetes

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

Scientists discover new cell type in the immune system

CoppaFeel!: Breast Cancer Doesn’t Discriminate, So Why Should Awareness?

The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Latest News